Clean Energy Technologies, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Clean Energy Technologies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $957.6K | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | $2.05M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $2.36M | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | $3.53M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $3.52M | Apr 28, 2015 |
| FY2013 | Dec 31, 2012 | $4.96M | Apr 15, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.42M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $6.69M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $2.66M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.30M | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $1.41M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.61M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $1.33M | May 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $4.55M | Apr 9, 2012 |
| FY2011 | Dec 31, 2010 | $2.80M | Apr 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $846.6K | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $460.8K | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $1.17M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $610.4K | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $751.1K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $657.2K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $520.7K | May 28, 2020 |
| FY2018 | Dec 31, 2017 | $412.9K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $764.3K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $668.9K | Apr 28, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($4.42M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($5.66M) | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $147.4K | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $297.6K | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | ($3.44M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.56M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($2.81M) | May 28, 2020 |
| FY2017 | Dec 31, 2017 | ($2.21M) | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | ($1.70M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($2.57M) | Apr 28, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.11M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($2.93M) | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | ($989.8K) | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | ($1.57M) | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | ($1.24M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($1.45M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.52M) | May 28, 2020 |
| FY2018 | Dec 31, 2017 | ($1.20M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($1.28M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($1.75M) | Apr 28, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $0 | Apr 15, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $449.5K | Apr 15, 2019 |
| FY2018 | Dec 31, 2017 | $375.8K | Apr 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.56M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($4.78M) | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | ($2.24M) | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | ($2.55M) | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | ($1.43M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.22M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($1.44M) | May 28, 2020 |
| FY2017 | Dec 31, 2017 | ($1.50M) | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | ($513.2K) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($617.6K) | Apr 28, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $4.6K | Jun 9, 2025 |
| FY2020 | Dec 31, 2019 | $8.0K | Apr 15, 2021 |
| FY2017 | Dec 31, 2016 | ($75.4K) | Apr 16, 2018 |
| FY2015 | Dec 31, 2014 | ($2.3K) | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | ($48.5K) | Apr 28, 2015 |
| FY2013 | Dec 31, 2012 | ($47.7K) | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | ($25.3K) | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | ($51.6K) | Apr 9, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $9.51M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $10.93M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $8.11M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $6.43M | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $4.12M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $4.31M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.82M | May 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.78M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $2.78M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $3.25M | Apr 28, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.57M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $5.06M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $6.24M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $8.15M | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $11.36M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $9.56M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $7.61M | May 28, 2020 |
| FY2018 | Dec 31, 2017 | $6.89M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $5.05M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $4.50M | Apr 28, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.94M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $5.11M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $1.88M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | ($1.70M) | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | ($7.24M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($5.25M) | Apr 15, 2021 |
| FY2020 | Dec 31, 2018 | ($4.80M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | ($4.11M) | May 28, 2020 |
| FY2011 | Dec 31, 2011 | $338.0K | Apr 9, 2012 |
| FY2011 | Dec 31, 2010 | $183.2K | Apr 9, 2012 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $748.0K | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $748.0K | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | $748.0K | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | $748.0K | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | $748.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $748.0K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $748.0K | May 28, 2020 |
| FY2018 | Dec 31, 2017 | $748.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $748.0K | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $748.0K | Apr 28, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($27.44M) | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | ($22.98M) | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | ($17.28M) | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | ($17.42M) | Jun 20, 2024 |
| FY2021 | Dec 31, 2020 | ($17.65M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($14.22M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($11.60M) | May 28, 2020 |
| FY2018 | Dec 31, 2017 | ($8.79M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($6.57M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($4.88M) | Apr 28, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $62.1K | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | $89.6K | Jun 9, 2025 |
| FY2021 | Dec 31, 2021 | $1.19M | Apr 15, 2022 |
| FY2021 | Dec 31, 2020 | $414.9K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $7.4K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $6.5K | May 28, 2020 |
| FY2017 | Dec 31, 2017 | $9.4K | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | $6.4K | Apr 16, 2018 |
| FY2017 | Dec 31, 2015 | $4.2K | Apr 16, 2018 |
| FY2016 | Dec 31, 2014 | $27.2K | Apr 28, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $257.9K | Jun 20, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 20, 2024 |
| FY2017 | Dec 31, 2017 | 0 | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 28, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Apr 15, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Jun 9, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Jun 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Apr 15, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Apr 15, 2021 |
| FY2017 | Dec 31, 2017 | 0 | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 28, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 28, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 45.33M | Jun 9, 2025 |
| FY2024 | Dec 31, 2023 | 39.15M | Jun 9, 2025 |
| FY2022 | Dec 31, 2022 | 37.17M | Jun 20, 2024 |
| FY2022 | Apr 15, 2022 | 38.50M | Jun 20, 2024 |
| FY2022 | Dec 31, 2021 | 23.59M | Jun 20, 2024 |
| FY2021 | Apr 15, 2021 | 965.17M | Apr 15, 2022 |
| FY2021 | Dec 31, 2020 | 943.57M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 753.91M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 555.58M | May 28, 2020 |
| FY2017 | Dec 31, 2017 | 210.88M | Apr 16, 2018 |